Lapam Capital
28
28M
26
7
0.07
1
- Stages of investment
- Areas of investment
Summary
The main office of represented VC is situated in the Beijing. The fund was located in Asia if to be more exact in China.
Among the most popular fund investment industries, there are Clinical Trials, Medical. Moreover, a startup needs to be at the age of 4-5 years to get the investment from the fund. For fund there is a match between the location of its establishment and the land of its numerous investments - China. Among the most popular portfolio startups of the fund, we may highlight Connect Biopharmaceuticals, Stemirna Therapeutics, Asieris Pharmaceuticals. The fund has exact preference in some founders of portfolio startups.
The usual cause for the fund is to invest in rounds with 4-5 partakers. Despite the Lapam Capital, startups are often financed by TF Capital, Qiming Venture Partners, XinYue Equity. The meaningful sponsors for the fund in investment in the same round are ZGC Group, Qiming Venture Partners, Zhongguancun VC Development Center. In the next rounds fund is usually obtained by Qiming Venture Partners, Northern Light Venture Capital, Cowin Capital.
The usual things for fund are deals in the range of 10 - 50 millions dollars. The real fund results show that this VC is 30 percentage points more often commits exit comparing to other companies. The fund is generally included in 2-6 deals every year. The high activity for fund was in 2017.
Investments analytics
Analytics
- Total investments
- 28
- Lead investments
- 7
- Exits
- 1
- Follow on index
- 0.07
- Investments by industry
- Biotechnology (21)
- Pharmaceutical (12)
- Health Care (10)
- Medical (9)
- Biopharma (5) Show 11 more
- Investments by region
-
- China (24)
- United States (3)
- Peak activity year
- 2021
Discover reliable insights
Leverage validated data, identify key contacts and secure funding opportunities for your business.Quantitative data
- Avg. startup age at the time of investment
- 10
- Group Appearance index
- 0.93
Need more data?
Get access to full data about investors, including their team, contact information, and historic data.
Latest deals
Company name | Deal date | Industry | Deal stage | Deal size | Location |
---|---|---|---|---|---|
Leads Biolabs | 08 Oct 2021 | Biotechnology, Health Care, Pharmaceutical | Late Stage Venture | 100M | Nanjing, Jiangsu, China |
Rapafusyn Pharmaceuticals | 20 Jun 2024 | Early Stage Venture | 28M | United States, Maryland, Baltimore |
Similar funds
By same location
By same geo focus
By doing lead investments
At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).
Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.